Combined Effects of Buteyko Breathing Technique and Chest Wall Mobilization on Pulmonary Functions and Quality of Life

July 31, 2024 updated by: Riphah International University

Combined Effects of Buteyko Breathing Technique and Chest Wall Mobilization on Pulmonary Functions and Quality of Life in Chronic Smokers

The study aims to evaluate the effects of Buteyko breathing techniques with and without chest wall mobilization on pulmonary functions, and quality of life in chronic smokers. The study design will be a randomized clinical trial. The study will be completed in 10 months after the approval of the synopsis from the Ethical Committee of RCRS & AHS. A non-probability convenient sampling technique will be used to recruit the individuals. Group 1-Buteyko breathing technique + Chest Wall Mobilization and Group 2-Buteyko Breathing Technique + Without Chest Wall Mobilization

Study Overview

Detailed Description

This randomized clinical trial will evaluate the combined effect of the Buteyko breathing technique and chest wall mobilization on pulmonary functions and quality of life in chronic smokers. A sample size of 40 is calculated through a non-probability convenient sampling technique. Participants will be recruited into Group 1 and Group 2 by lottery method (without replacement). Group 1 will be engaged in the Buteyko breathing technique + Chest Wall Mobilization and Group 2 will undergo Buteyko Breathing Technique + Without Chest Wall Mobilization. Pre and post-outcome measures of pulmonary functions will be measured through a digital spirometer and quality of life will be assessed by the St George Quality of Life Questionnaire.

Spirometry assesses the amount and speed of air that can be inhaled and exhaled. Key measurements include Forced Vital Capacity (FVC): The maximum volume of air forcefully exhaled after a full inhalation. Forced Expiratory Volume in 1 Second (FEV1): The volume of air exhaled in the first second of the FVC test, indicates how quickly the lungs can be emptied.

St Saint Georg quality of life questionnaire for assessing the QOL. The SGRQ is a standardized self-administered airway disease-specific questionnaire divided into 2 subscales, a total of 12 questions. For each subscale and the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both male and female participants were included
  • The age of participants was 40 -55 years.
  • Individuals who fulfilled the criteria of smoking which is calculated by multiplying the number of packs smoked per day by the number of years smoked were included.
  • Individuals who are current smokers or history of long-term smoking were included.
  • Predicted values FEV1 < 75% and FEV1/FVC <70%

Exclusion Criteria:

  • Participants with neurological disorders were excluded
  • Participants with musculoskeletal disorders were excluded as it affects the physical activity of the 6-minute walk test.
  • Participants having any pulmonary complications or lung disease were excluded.
  • Participants previously involved in any other exercise or physical activity were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Buteyko breathing technique, Chest wall mobilization
Deep breathing exercises for 5 minutes. After the 5-minute resting interval Buteyko breathing technique and chest wall mobilization of 5 minutes Chest wall mobilization with 8-10 repetitions. Total time duration will be 30 minutes. 2 sessions per week
Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.
It started with positioning, sitting or standing with good posture, and relaxing shoulders and arms. Hands were placed on the chest with fingers wide and thumbs on side of ribcage. Inhale deep breaths with expansion of chest and hands move outward. Exhale slowly allowed the chest to drop and the hands to move inward.
Active Comparator: Buteyko breathing technique
Deep breathing for 5 minutes as a baseline Buteyko technique of 2 sets of 8-10 repetitions for 2 days a week. Chest wall mobilization will not be included in Group 2. Repeat the breathing cycle for 5-10 minutes, 2-3 times a day. Total time duration will be 30 minutes.
Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FEV1(Forced Expiratory Volume per second)
Time Frame: Pre and Post after 1 week
Pulmonary Function Test using Digital Spirometer. • Forced Vital Capacity (FVC): the amount of air that can be forcefully exhaled after taking a complete breath.
Pre and Post after 1 week
FVC(Forced Vital Capacity)
Time Frame: Pre and Post after 1 week
Pulmonary Function Test using Digital Spirometer. the amount of air expelled during the first second of the forced ventilation test (FVC), which measures how rapidly the lungs can empty.
Pre and Post after 1 week
St George Questionnaire
Time Frame: Pre and Post after 1 week
To assess the Quality of Life. The total questionnaire score is 100 (highest impairment) while the subscale values range from zero (no impairment)
Pre and Post after 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tasneem Shehzadi, Mphil, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2024

Primary Completion (Estimated)

August 13, 2024

Study Completion (Estimated)

September 10, 2024

Study Registration Dates

First Submitted

June 24, 2024

First Submitted That Met QC Criteria

July 31, 2024

First Posted (Estimated)

August 5, 2024

Study Record Updates

Last Update Posted (Estimated)

August 5, 2024

Last Update Submitted That Met QC Criteria

July 31, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • REC/RCR & AHS/23/0373

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Smokers

Clinical Trials on Buteyko breathing technique

Subscribe